Cadberonn Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 42.94%
(FY 2022)
- Profit 25.32%
(FY 2022)
- Ebitda 132.95%
(FY 2022)
- Net Worth 100.90%
(FY 2022)
- Total Assets 33.04%
(FY 2022)
About Cadberonn Life Sciences
The Corporate was formerly known as Cadberonn Private Limited. The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Eramanniyil Rajnarayanan, Vellithodi Jayaprasad, Thakayathil Askarali, and One other member serve as directors at the Company.
- CIN/LLPIN
U52609KL2016PTC045728
- Company No.
045728
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2016
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cadberonn Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eramanniyil Rajnarayanan  | Director | 04-Jun-2016 | Current |
| Vellithodi Jayaprasad | Director | 11-May-2016 | Current |
| Thakayathil Askarali | Director | 11-May-2016 | Current |
| Rajesh | Director | 04-Jun-2016 | Current |
Financial Performance of Cadberonn Life Sciences.
Cadberonn Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.94% increase. The company also saw a substantial improvement in profitability, with a 25.32% increase in profit. The company's net worth Soared by an impressive increase of 100.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cadberonn Life Sciences?
Unlock access to Cadberonn Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Facilicare Fm Facility Services Private LimitedActive 6 years 4 monthsThakayathil Askarali is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cadberonn Life Sciences?
Unlock and access historical data on people associated with Cadberonn Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cadberonn Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadberonn Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.